Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.

Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • @DrPopEnglish
    10•1 year ago

    But that ignores the nuance of the situation. If the application is to help people survive why shouldn’t the government tell them they can’t overcharge people?